Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA ABBOTT INDIA GLENMARK PHARMA/
ABBOTT INDIA
 
P/E (TTM) x -31.4 50.0 - View Chart
P/BV x 2.9 18.2 15.7% View Chart
Dividend Yield % 0.3 1.2 21.6%  

Financials

 GLENMARK PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
ABBOTT INDIA
Mar-23
GLENMARK PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs48722,482 2.2%   
Low Rs34916,156 2.2%   
Sales per share (Unadj.) Rs460.42,517.0 18.3%  
Earnings per share (Unadj.) Rs13.4446.8 3.0%  
Cash flow per share (Unadj.) Rs35.0479.7 7.3%  
Dividends per share (Unadj.) Rs2.50325.00 0.8%  
Avg Dividend yield %0.61.7 35.5%  
Book value per share (Unadj.) Rs335.11,480.5 22.6%  
Shares outstanding (eoy) m282.1721.25 1,327.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.97.7 11.8%   
Avg P/E ratio x31.343.2 72.3%  
P/CF ratio (eoy) x11.940.3 29.6%  
Price / Book Value ratio x1.213.0 9.6%  
Dividend payout %18.772.7 25.7%   
Avg Mkt Cap Rs m117,953410,513 28.7%   
No. of employees `000NANA-   
Total wages/salary Rs m27,8105,636 493.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,90153,487 242.9%  
Other income Rs m3,1681,543 205.3%   
Total revenues Rs m133,06955,030 241.8%   
Gross profit Rs m15,12512,055 125.5%  
Depreciation Rs m6,113700 873.6%   
Interest Rs m3,496160 2,186.3%   
Profit before tax Rs m8,68512,738 68.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,9113,244 151.4%   
Profit after tax Rs m3,7749,494 39.8%  
Gross profit margin %11.622.5 51.7%  
Effective tax rate %56.525.5 222.0%   
Net profit margin %2.917.8 16.4%  
BALANCE SHEET DATA
Current assets Rs m98,73730,251 326.4%   
Current liabilities Rs m50,45512,060 418.4%   
Net working cap to sales %37.234.0 109.3%  
Current ratio x2.02.5 78.0%  
Inventory Days Days787 7.7%  
Debtors Days Days1152 5,324.6%  
Net fixed assets Rs m76,92015,135 508.2%   
Share capital Rs m282213 132.8%   
"Free" reserves Rs m94,28131,248 301.7%   
Net worth Rs m94,56331,460 300.6%   
Long term debt Rs m38,5210-   
Total assets Rs m175,65845,386 387.0%  
Interest coverage x3.580.7 4.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.71.2 62.8%   
Return on assets %4.121.3 19.5%  
Return on equity %4.030.2 13.2%  
Return on capital %9.241.0 22.3%  
Exports to sales %00.4 0.0%   
Imports to sales %010.8 0.0%   
Exports (fob) Rs mNA221 0.0%   
Imports (cif) Rs mNA5,765 0.0%   
Fx inflow Rs m46,464310 14,998.0%   
Fx outflow Rs m12,7125,818 218.5%   
Net fx Rs m33,751-5,508 -612.8%   
CASH FLOW
From Operations Rs m6,2548,934 70.0%  
From Investments Rs m-5,285-1,477 357.8%  
From Financial Activity Rs m-775-6,387 12.1%  
Net Cashflow Rs m3251,070 30.4%  

Share Holding

Indian Promoters % 46.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 34.7 8.9 388.7%  
FIIs % 23.7 0.2 13,172.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 25.0 213.3%  
Shareholders   209,931 72,252 290.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Glenmark Pharma vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs Abbott India Share Price Performance

Period Glenmark Pharma Abbott India S&P BSE HEALTHCARE
1-Day -0.57% 0.74% 1.18%
1-Month 5.16% -5.97% -0.75%
1-Year 112.94% 24.80% 61.82%
3-Year CAGR 27.51% 21.40% 18.16%
5-Year CAGR 8.05% 29.91% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.